These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1912329)

  • 21. New designer drugs N-(1-phenylcyclohexyl)-2-ethoxyethanamine (PCEEA) and N-(1-phenylcyclohexyl)-2-methoxyethanamine (PCMEA): Studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.
    Sauer C; Peters FT; Staack RF; Fritschi G; Maurer HH
    J Mass Spectrom; 2008 Mar; 43(3):305-16. PubMed ID: 17968862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex-dependent differences in the pharmacological actions and pharmacokinetics of phencyclidine in rats.
    Nabeshima T; Yamaguchi K; Yamada K; Hiramatsu M; Kuwabara Y; Furukawa H; Kameyama T
    Eur J Pharmacol; 1984 Jan; 97(3-4):217-27. PubMed ID: 6538506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the major metabolite of phencyclidine, the trans isomer of 4-phenyl-4-(1-piperidinyl)cyclohexanol, on [3H]N-(1-[2-thienyl] cyclohexyl)-3,4-piperidine ([3H]TCP) binding and [3H]dopamine uptake in the rat brain.
    Baba A; Yamamoto T; Yamamoto H; Suzuki T; Moroji T
    Neurosci Lett; 1994 Nov; 182(1):119-21. PubMed ID: 7891876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of phencyclidine metabolism by phencyclidine, ketamine, ethanol, phenobarbital and isosafrole.
    Kammerer RC; Schmitz DA; Hwa JJ; Cho AK
    Biochem Pharmacol; 1984 Feb; 33(4):599-604. PubMed ID: 6704176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of brain calcium antagonist binding by phencyclidine and related compounds.
    Bolger GT; Rafferty MF; Skolnick P
    Pharmacol Biochem Behav; 1986 Mar; 24(3):417-23. PubMed ID: 2939463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, phencyclidine-like pharmacology, and antiischemic potential of meta-substituted 1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridines.
    Thurkauf A; de Costa B; Mattson MV; France CP; Price MT; Olney JW; Woods JH; Jacobson AE; Rice KC
    J Med Chem; 1990 Aug; 33(8):2211-5. PubMed ID: 2374147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydroxy metabolites of phencyclidine. Identification and quantitation of two novel metabolites.
    Gole DJ; Pirat JL; Kamenka JM; Domino EF
    Drug Metab Dispos; 1988; 16(3):386-91. PubMed ID: 2900729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic phencyclidine treatment decreases phencyclidine and dopamine receptors in rat brain.
    Quirion R; Bayorh MA; Zerbe RL; Pert CB
    Pharmacol Biochem Behav; 1982 Oct; 17(4):699-702. PubMed ID: 6294678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the molecular mechanism of bioactivation of the selective nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Chiba K; Peterson LA; Castagnoli KP; Trevor AJ; Castagnoli N
    Drug Metab Dispos; 1985; 13(3):342-7. PubMed ID: 2861994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monohydroxymetabolites of phencyclidine (PCP): activities and urinary excretion by rat, dog and mouse.
    Cone EJ; Vaupel DB; Yousefnejad D
    J Pharm Pharmacol; 1982 Mar; 34(3):197-9. PubMed ID: 6121902
    [No Abstract]   [Full Text] [Related]  

  • 31. Binding of phencyclidine to rat brain membranes: technical aspect.
    Vincent JP; Vignon J; Kartalovski B; Lazdunski M
    Eur J Pharmacol; 1980 Nov; 68(1):73-7. PubMed ID: 6450049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of 1-(1-phenylcyclohexyl)piperidine HC1 (phencyclidine, Sernyl) on respiration and related reactions of liver mitochondria in vitro.
    Lees H
    Biochem Pharmacol; 1968 May; 17(5):845-8. PubMed ID: 4231271
    [No Abstract]   [Full Text] [Related]  

  • 33. Persistence of phencyclidine in fetal brain.
    Ahmad G; Halsall LC; Bondy SC
    Brain Res; 1987 Jul; 415(1):194-6. PubMed ID: 3620944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoradiographic distribution of phencyclidine receptors in the rat brain using [3H]1-(1-(2-thienyl)cyclohexyl)piperidine ([3H]TCP).
    Contreras PC; Quirion R; O'Donohue TL
    Neurosci Lett; 1986 Jun; 67(2):101-6. PubMed ID: 3014394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phenolic metabolite of phencyclidine: the formation of a pharmacologically active metabolite by rat liver microsomes.
    Ohta S; Masumoto H; Takeuchi K; Hirobe M
    Drug Metab Dispos; 1987; 15(4):583-4. PubMed ID: 2888636
    [No Abstract]   [Full Text] [Related]  

  • 36. Compared properties of central and peripheral binding sites for phencyclidine.
    Vincent JP; Vignon J; Kartalovski B; Lazdunski M
    Eur J Pharmacol; 1980 Nov; 68(1):79-82. PubMed ID: 6450050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Importance of reactive metabolites to the in vivo hepatic clearance of phencyclidine (PCP).
    Zorbas MA; Owens SM
    NIDA Res Monogr; 1990; 105():429-30. PubMed ID: 1876062
    [No Abstract]   [Full Text] [Related]  

  • 38. Metabolism of phencyclidine. The role of the carbinolamine intermediate in the formation of lactam and amino acid metabolites of nitrogen heterocycles.
    Baker JK; Little TL
    J Med Chem; 1985 Jan; 28(1):46-50. PubMed ID: 3965713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of [3H] phencyclidine ([3H] PCP) and [3H] N-[1-(2-thienyl) cyclohexyl] piperidine ([3H] TCP) binding properties to rat and human brain membranes.
    Vignon J; Chaudieu I; Allaoua H; Journod L; Javoy-Agid F; Agid Y; Chicheportiche R
    Life Sci; 1989; 45(26):2547-55. PubMed ID: 2615554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of phencyclidine on oxygen consumption of rat brain mitochondria in vitro and in vivo.
    Millo S; Chari-Bitron A
    Biochem Pharmacol; 1973 Jul; 22(13):1661-5. PubMed ID: 4729812
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.